Surgical treatment of non–functioning pancreatic tumor

Alina Ioana Puscașu, Andra Rădulescu, Răzvan Constantin Anghel, Delia Gabriela Ciobanu Apostol, Elena Cotea, Alin Vasilescu


Pancreatic neuroendocrine tumors have a rare annual incidence in the general population and they are classified into functional and non-functional tumors. Non-functioning tumors represent the majority. We report an uncommon non-functional neoplasm that developed into the pancreatic isthmus. A 70-year-old woman presented at the hospital with abdominal pain, nausea and vomiting. The abdominal echography revealed a hypoechoic mass of 65/54 mm with dilatation of the upstream Wirsung duct. Non-contrast-enhanced computed tomographic demonstrated a well-enhanced mass of 4/5/6.5 cm on the head of the pancreas. An endocrine tumor of the pancreas was considered as a preoprerative diagnosis and pancreatectomy was performed with pancreato-jejunum anastomosis- the Beger surgery. As a result, a non-functional endocrine tumor of the pancreas was confirmed anatomo-pathologically. The clinical manifestation of non-functioning endocrine pancreatic tumors is characterized by nonspecific symptoms. They represent a group of neoplasms which can delay the real diagnosis. Currently, CT scans are most used for detection. A rare case of non-functional neuroendocrine pancreatic neoplasm with extensive growth within the head and isthmus part of the pancreas was presented. An early detection of non-functioning endocrine neoplasm of the pancreas is very important and curative resection should be tried for a good prognosis.


non-functioning pancreatic tumor, central pancreatectomy, omega loop, Braun anastomosis, Beger procedure

Full Text:



Gullo L, Migliori M, Falconi M, et al. Nonfunctioning pancreatic endocrine tumors: A multicenter clinical study. Am J Gastroenterol. 2003; 98(11):2435-2439.

Falconi M, Plockinger U, Kwekkeboom DJ, et al. Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology. 2006; 84(3):196-211.

Farkas G. Surgical treatment of neuroendocrine tumors of the pancreas. Magy Onkol. 2003; 47(4):345-347.

Sarmiento JM, Que FG, Grant CS, Thompson GB, Farnell MB, Nagorney DM. Concurrent resection of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 2002; 132(6):976-982.

Matthew BD, Smith TI, Kercher KW, Holder WD Jr, Heniford BT. Surgical experience with functioning pancreatic neuroendocrine tumors. Am Surg. 2002; 68(8):660-5.

Kazuhiro H. Recent standardization of treatment strategy for pancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16(36):4519–4525.

Appetecchia M, Baldelli R. Somatostatin analogues in the treatment of gastro-enteropancreatic neuroendocrine tumours, current aspects and new perspectives. J Exp Clin Cancer Res 2010; 29:19.

Haynes AB, Deshpande V, Ingkakul T, et al. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg. 2011; 146(5):534-538.

Balzano G, Zerbi A, Veronesi P, Cristallo M, Di Carlo V. Surgical treatment of benign and borderline neoplasms of the pancreatic body. Dig Surg. 2003; 20(6):506-510.

Yamaguchi K, Yokohata K, Ohkido M, et al. Which is less invasive – distal pancreatectomy or segmental resection. Int Surg. 2000; 85(4):297-302.

Triponez F, Goudet P, Dosseh, et al. Is surgery beneficial for MEN-1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analisys of 65 patients from the GTE. Word J Surg 2006; 30(5): 654-662.

Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR. Experience with nonfunctioning neuroendocrine neoplasms of the pancreas. Dig Surg 2005; 22(6):453-458.


Copyright (c) 2015 Archive of Clinical Cases

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975